What were the most common tigecycline-related adverse reactions in clinical trials involving complicated skin and soft tissue or intra-abdominal infections?

In clinical trials involving complicated skin and soft tissue or intra-abdominal infections, the most common tigecycline-related adverse reactions were reversible nausea (21%) and vomiting (13%), usually occurring on treatment days 1–2 and generally mild or moderate in severity.